Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 3/2012

01-03-2012 | Short Communication

A case of primary Sjögren’s syndrome presenting primarily with central nervous system vasculitic involvement

Authors: Zehra Isik Hasiloglu, Sait Albayram, Koray Tasmali, Burak Erer, Hakan Selcuk, Civan Islak

Published in: Rheumatology International | Issue 3/2012

Login to get access

Abstract

Sjögren’s syndrome is primarily a chronic systemic autoimmune disease that affects exocrine organs. Neurologic symptoms frequently present as peripheral neuropathy due to small vessel vasculitis. Type and prevalence of central nervous system involvement are still controversial. In this report, we present a 35-year-old woman with primary Sjögren’s syndrome with central nervous system vasculitic involvement.
Literature
1.
Garcia-Carrasco M, Ramos-Casals M, Rosas J et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 81:270–280PubMedCrossRef
2.
Morgen K, McFarland HF, Pillemer SR (2004) Central nervous system disease in primary Sjögren syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 34:623–630PubMedCrossRef
3.
Sanahuja J, Ordon˜ ez-Palau S, Begué R, Brieva L, Boquet D (2008) Primary Sjögren syndrome with tumefactive central nervous system involvement. AJNR Am J Neuroradiol 29:1878–1879PubMedCrossRef
4.
Sjögren H (1935) Zur kenntnis der keratoconjunctivitis sicca: allgemeine symtomatologie und aetiologie. Acta Ophthalmol 57:983–996
5.
Delalande S, de Seze J, Fauchais AL et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine 83:280–291PubMedCrossRef
6.
Shearn M (1971) Sjögren’s syndrome. WB Saunders, Philadelphia
7.
Talal N, Sokoloff L, Barth WF (1967) Extrasalivary lymphoid abnormalities in Sjögren’s syndrome (reticulum cell sarcoma, pseudolymphoma, macroglobulinemia). Am J Med 43:50–65PubMedCrossRef
8.
Alexander EL, Ranzenbach MR, Kumar AJ, Kozachuk WE, Rosenbaum AE, Patronas N et al (1994) Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjogren’s syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 44:899–908PubMed
9.
Alexander EL, Craft C, Dorsch C, Moser RL, Provost TT, Alexander GE (1982) Necrotizing arteritis and spinal subarachnoid hemorrhage in Sjögren’s syndrome. Ann Neurol 11:632–635PubMedCrossRef
10.
Alexander EL, Provost TT, Stevens MB, Alexander GE (1982) Neurologic complications of primary Sjögren’s syndrome. Medicine 61:247–257PubMedCrossRef
11.
Alexander EL (1986) Central nervous system (CNS) manifestations of primary Sjögren’s syndrome: an overview. Scand J Rheumatol Suppl 61:161–165PubMed
12.
Alexander EL (1993) Neurologic disease in Sjögren’s syndrome: a mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19:869–908PubMed
13.
Molina R, Provost TT, Alexander EL (1985) Peripheral inflammatory vascular disease in Sjögren’s syndrome. Association with nervous system complications. Arthritis Rheum 28:1341–1347PubMedCrossRef
14.
Ferreiro JE, Robalino BD, Saldana MJ (1987) Primary Sjögren’s syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis. Am J Med 82:1227–1232PubMedCrossRef
Metadata
Title
A case of primary Sjögren’s syndrome presenting primarily with central nervous system vasculitic involvement
Authors
Zehra Isik Hasiloglu
Sait Albayram
Koray Tasmali
Burak Erer
Hakan Selcuk
Civan Islak
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1824-z

Other articles of this Issue 3/2012

Rheumatology International 3/2012 Go to the issue

Original Article

Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients

Original Article

Evaluation of metabolic syndrome in patients with chronic low back pain

Letter to the Editor

A potential explanation of the reported low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus

Original Article

Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope

Original Article

Propylthiouracil-induced autoimmune syndromes: 11 case report

Short Communication

Healthcare-associated infections in rheumatology in Japan

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits